B O O K - American College of Rheumatology

tuesday
6:45 PM
Results from the PMR Classification Criteria Study
Eric L. Matteson, MD; Mayo Clinic; Rochester, MN
7:05 PM
Update on Trials of Biologic Agents and Leflunomide in PMR
and GCA
Bhaskar Dasgupta, MD; Southend University Hospital; Essex,
United Kingdom
7:25 PM
A Study of Educational Needs of Patients with PMR and GCA
Richard Watts, DM; Ipswich Hospital; Ipswich, United Kingdom
7:45 PM
Update on Study of Temporal Artery Ultrasound Versus Biopsy
in GCA
Raashid Luqmani, DM; Nuffield Department of Orthopaedics,
Rheumatology and Musculoskeletal Sciences; Oxford, United
Kingdom
Session Overview:
The study group will be the forum for presenting results from
the Prospective PMR Classification Criteria Study. It will also
feature updates on therapeutic trials in PMR and GCA with
leflunomide and biologic agents. A study of educational needs of
patients with PMR and GCA will be presented. Attendees will be
updated on study of temporal artery ultrasound versus biopsy
in GCA.
Upon completion of this session, participants should be able to:
• describe results from the PMR classification criteria study
• update on trials of leflunomide and biologic agents in PMR
and GCA
• explain a study of educational needs of patients with PMR and
GCA
• explain the study of temporal artery ultrasound versus biopsy
in GCA
B314
Psoriatic Arthritis and Periarticular Imaging: Focus on
Enthesitis, Dactylitis, and Nail Disease
Moderators: Elaine Husni, MD, MPH; Cleveland Clinic
Foundation; Cleveland, OH
Philip Helliwell, MD, PhD; University of Leeds; Leeds, United
Kingdom
6:45 PM
The Role of Enthesitis in the Pathogenesis of Psoriatic Arthritis
Dennis McGonagle, PhD; University of Leeds; Leeds, United
Kingdom
7:10 PM
Clinical Assessment of Enthesitis: How Should This Be Done?
Philip Helliwell, MD, PhD; University of Leeds; Leeds, United
Kingdom
7:35 PM
Use of Ultrasound and Magnetic Resonance Imaging: Focus on
Periarticular Disease in Patients with Psoriatic Arthritis
Ralf G. Thiele, MD; University of Rochester; Rochester, NY
Session Overview:
Psoriatic arthritis is a unique inflammatory arthritis that
encompasses both skin and joint involvement with common
periarticular manifestations such as enthesitis and dactylitis. In
fact, the initial insult may be enthesitis rather than the synovium
and current area of research interest is in the early evaluation
and detection of these clinical parameters. Therapeutic decisions
may be influenced by the presence of active enthesis/dactylitis
and current techniques of clinical examination and standard
radiographs may underestimate the overall inflammatory
burden. With the advances of imaging modalities, we will
explore the utility of ultrasound and MRI for psoriatic diseases.
We hope to bring together multidisciplinary disciplines in
musculoskeletal radiologist and rheumatologist to help advance
the field of psoriatic arthritis.
Upon completion of this session, participants should be able to:
• describe the overview of advances in imaging such as
ultrasound in the utility of periarticular tissues in psoriatic
arthritis
• explore the relationship of immunohistology and imaging of
skin and joints for psoriatic diseases
• identify the pathobiology and immuno-pathology underlying
enthesitis in psoriatic disorders
• appreciate the several clinical scoring methods for enthesitis,
their reliability, sensitivity and specificity
B309
Sjögren’s Syndrome
Moderators: Gabor G. Illei, MD; NIDCR/NIH; Bethesda, MD
Nikolay P. Nikolov, MD; FDA/CDER/OND; Silver Spring, MD
6:45 PM
Animal Models in Sjögren’s Syndrome: Are They Any Good?
Umesh Desmukh, PhD; University of Virginia; Charlottesville, VA
7:10 pm
From Bench to Bedside: Biological Markers of Disease Activity
and Prognosis in Primary Sjögren’s Syndrome
Jacques-Eric Gottenberg, MD, PhD; University of Strasbourg,
France
7:35 pm
Autonomic Dysfunction: An Often Overlooked Feature of
Primary Sjogren’s Syndrome
Thomas Mandl, MD, PhD: Malmo University Hospital; Malmo,
Sweden
Session Overview:
The study group will address three topics ranging from animal
models to clinical aspects of Sjögren’s syndrome providing inside
in both the pathogenesis and clinical management of Sjögren’s
syndrome. Speakers will discuss the role of B lymphocyte
subsets and inflammatory mediators in the pathogenesis of
Sjögren’s and their potential as biomarkers, the advantages
and limitations of various animal models and their relevance
to human disease and the pathogenesis and treatment
of autonomic dysfunction, one of the most challenging
manifestation of Sjögren’s Syndrome. All three speakers will
cover the basic aspects and the clinical implications of their
topics.
92
2010 Program Book